Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-01-03 @ 12:14 AM
Study NCT ID:
NCT01186458
Status:
TERMINATED
Last Update Posted:
2016-10-24
First Post:
2010-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Sponsor:
Hoosier Cancer Research Network
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HOG LYM08-134
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None